What Happened?
Houston, TX-based AlloVir Appointed Brett Giroir as President and Chief Executive Officer
About the Company
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
About the Person
Brett Giroir is President and Chief Executive Officer at AlloVir. Previously, Brett held various senior HR leadership roles in the industry.
Info Source
News
Short Profile